Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

BMGL US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

BMGL US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Basel Medical Group Ltd(BMGL US)

$0.47-0.1017.54%Ext:$0.47-0.000.84%(Market Closed · 00:50:05 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized

Basel Medical Group Ltd(BMGL US)

$0.47-0.1017.54%Ext:$0.47-0.000.84%(Market Closed · 00:50:05 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

SEC Filings

Financials(4)

Expand
  • 20-FFY 2026ended 30 Jun 202630 Oct
  • 20-F/AFY 2025ended 30 Jun 202513 Mar
  • 20-FFY 2025ended 30 Jun 202517 Nov 2025
  • NT 20-FFY 2025ended 30 Jun 202527 Oct 2025

Events(32)

Expand
  • 6-KCurrent report (foreign private issuer)29 Oct
  • 6-KCurrent report (foreign private issuer)13 Oct
  • 6-KCurrent report (foreign private issuer)9 Oct
  • 6-KCurrent report (foreign private issuer)2 Sep
  • 6-KCurrent report (foreign private issuer)10 Aug
  • 6-KCurrent report (foreign private issuer)10 Jul
  • 6-KCurrent report (foreign private issuer)26 Jun
  • 6-KCurrent report (foreign private issuer)10 Jun
  • 6-KCurrent report (foreign private issuer)5 Jun
  • 6-KCurrent report (foreign private issuer)30 Mar
  • 6-KCurrent report (foreign private issuer)24 Mar
  • 6-KCurrent report (foreign private issuer)23 Jan
  • 6-KCurrent report (foreign private issuer)21 Jan
  • 6-KCurrent report (foreign private issuer)1 Dec 2025
  • 6-KCurrent report (foreign private issuer)21 Aug 2025

Insider Ownership(10)

Expand
  • Form 3Yang Xinwen21 Oct
  • Form 3Hong Frederick Shieh Ming1 Oct
  • Form 3Neo Alton Chun How22 Jul
  • Form 3Soong Kwek Yoon21 Apr
  • Form 3Lu Jianing JN15 Apr
  • Form 3CHEN TONY14 Apr
  • Form 3Chhoa Darren Yen Feng14 Apr
  • Form 3Tan Boon Chye14 Apr
  • Form 3Fung Keng Leong14 Apr
  • Form 3FREUDENTHALER PAUL D4 Mar

Beneficial Ownership(1)

Expand
  • SC 13GBasel Medical Group Ltd30 Apr 2025

Registrations(18)

Expand
  • 424B4Prospectus filing (Rule 424(b)(4))8 Oct
  • F-1/ARegistration statement (foreign issuer, amendment)23 Sep
  • F-1Registration statement (foreign issuer)17 Sep
  • DRSDraft registration statement31 Jul
  • 424B4Prospectus filing (Rule 424(b)(4))25 Feb 2025
  • 424B4Prospectus filing (Rule 424(b)(4))25 Feb 2025
  • 8-A12BRegistration of securities (Section 12(b))14 Feb 2025
  • F-1/ARegistration statement (foreign issuer, amendment)13 Feb 2025
  • FWPFree writing prospectus13 Dec 2024
  • F-1/ARegistration statement (foreign issuer, amendment)3 Dec 2024
  • F-1/ARegistration statement (foreign issuer, amendment)14 Nov 2024
  • F-1/ARegistration statement (foreign issuer, amendment)4 Nov 2024
  • F-1Registration statement (foreign issuer)13 Sep 2024
  • DRS/ADraft registration statement (amendment)28 Aug 2024
  • DRS/ADraft registration statement (amendment)21 Jun 2024

Filing Review Correspondence(11)

Expand
  • CORRESPFiling review correspondence14 Feb 2025
  • CORRESPFiling review correspondence14 Feb 2025
  • CORRESPFiling review correspondence3 Dec 2024
  • CORRESPFiling review correspondence14 Nov 2024
  • CORRESPFiling review correspondence4 Nov 2024
  • CORRESPFiling review correspondence13 Sep 2024
  • DRSLTRFiling review correspondence (DRSLTR)28 Aug 2024
  • DRSLTRFiling review correspondence (DRSLTR)21 Jun 2024
  • DRSLTRFiling review correspondence (DRSLTR)8 May 2024
  • DRSLTRFiling review correspondence (DRSLTR)18 Mar 2024
  • DRSLTRFiling review correspondence (DRSLTR)9 Feb 2024

SEC Orders And Notices(2)

Expand
  • EFFECTNotice of effectiveness30 Sep
  • EFFECTNotice of effectiveness18 Feb 2025

Other(1)

Expand
  • CERTCERT21 Feb 2025

Financials(4)

Expand
  • 20-FFY 2026ended 30 Jun 202630 Oct
  • 20-F/AFY 2025ended 30 Jun 202513 Mar
  • 20-FFY 2025ended 30 Jun 202517 Nov 2025
  • NT 20-FFY 2025ended 30 Jun 202527 Oct 2025

Events(32)

Expand
  • 6-KCurrent report (foreign private issuer)29 Oct
  • 6-KCurrent report (foreign private issuer)13 Oct
  • 6-KCurrent report (foreign private issuer)9 Oct
  • 6-KCurrent report (foreign private issuer)2 Sep
  • 6-KCurrent report (foreign private issuer)10 Aug
  • 6-KCurrent report (foreign private issuer)10 Jul
  • 6-KCurrent report (foreign private issuer)26 Jun
  • 6-KCurrent report (foreign private issuer)10 Jun
  • 6-KCurrent report (foreign private issuer)5 Jun
  • 6-KCurrent report (foreign private issuer)30 Mar
  • 6-KCurrent report (foreign private issuer)24 Mar
  • 6-KCurrent report (foreign private issuer)23 Jan
  • 6-KCurrent report (foreign private issuer)21 Jan
  • 6-KCurrent report (foreign private issuer)1 Dec 2025
  • 6-KCurrent report (foreign private issuer)21 Aug 2025

Insider Ownership(10)

Expand
  • Form 3Yang Xinwen21 Oct
  • Form 3Hong Frederick Shieh Ming1 Oct
  • Form 3Neo Alton Chun How22 Jul
  • Form 3Soong Kwek Yoon21 Apr
  • Form 3Lu Jianing JN15 Apr
  • Form 3CHEN TONY14 Apr
  • Form 3Chhoa Darren Yen Feng14 Apr
  • Form 3Tan Boon Chye14 Apr
  • Form 3Fung Keng Leong14 Apr
  • Form 3FREUDENTHALER PAUL D4 Mar

Beneficial Ownership(1)

Expand
  • SC 13GBasel Medical Group Ltd30 Apr 2025

Registrations(18)

Expand
  • 424B4Prospectus filing (Rule 424(b)(4))8 Oct
  • F-1/ARegistration statement (foreign issuer, amendment)23 Sep
  • F-1Registration statement (foreign issuer)17 Sep
  • DRSDraft registration statement31 Jul
  • 424B4Prospectus filing (Rule 424(b)(4))25 Feb 2025
  • 424B4Prospectus filing (Rule 424(b)(4))25 Feb 2025
  • 8-A12BRegistration of securities (Section 12(b))14 Feb 2025
  • F-1/ARegistration statement (foreign issuer, amendment)13 Feb 2025
  • FWPFree writing prospectus13 Dec 2024
  • F-1/ARegistration statement (foreign issuer, amendment)3 Dec 2024
  • F-1/ARegistration statement (foreign issuer, amendment)14 Nov 2024
  • F-1/ARegistration statement (foreign issuer, amendment)4 Nov 2024
  • F-1Registration statement (foreign issuer)13 Sep 2024
  • DRS/ADraft registration statement (amendment)28 Aug 2024
  • DRS/ADraft registration statement (amendment)21 Jun 2024

Filing Review Correspondence(11)

Expand
  • CORRESPFiling review correspondence14 Feb 2025
  • CORRESPFiling review correspondence14 Feb 2025
  • CORRESPFiling review correspondence3 Dec 2024
  • CORRESPFiling review correspondence14 Nov 2024
  • CORRESPFiling review correspondence4 Nov 2024
  • CORRESPFiling review correspondence13 Sep 2024
  • DRSLTRFiling review correspondence (DRSLTR)28 Aug 2024
  • DRSLTRFiling review correspondence (DRSLTR)21 Jun 2024
  • DRSLTRFiling review correspondence (DRSLTR)8 May 2024
  • DRSLTRFiling review correspondence (DRSLTR)18 Mar 2024
  • DRSLTRFiling review correspondence (DRSLTR)9 Feb 2024

SEC Orders And Notices(2)

Expand
  • EFFECTNotice of effectiveness30 Sep
  • EFFECTNotice of effectiveness18 Feb 2025

Other(1)

Expand
  • CERTCERT21 Feb 2025